RE: Last RNS CEO QUOTE23 Oct 2023 10:56
Bit like these words from Fiona
"pre|CISIONTM is a tumour microenvironment targeting platform aimed at delivering potent warheads directly to the tumour, reducing systemic exposure and toxicity and thereby dramatically improving tolerability to enhance efficacy of the treatment. This targeted approach to delivering cancer treatments is now clinically validated by our lead molecule AVA6000."
Clearly going very badly.